Assess the Oral Bioavailability of a New ABT-263 Formulation in Subjects With Cancer

Clinical trial NCT00982566 · COMPLETED

Trial details

NCT number: NCT00982566
Sponsor: AbbVie
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Lymphoid Malignancy Solid Tumors

Start date: 2009-10-01
Primary completion: 2010-10-01
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.